SEC Filing Summary: Disc Medicine, Inc. (IRON)
Business Context and Reporting Period
This Form 8-K was filed on August 8, 2024, by Disc Medicine, Inc., a Delaware corporation. The filing serves as a Current Report to announce the company's financial results for the quarter ended June 30, 2024, and to provide a corporate update. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
No specific material changes versus the prior comparable period are quantified in the filing text. The document indicates that the company announced its results for the quarter ended June 30, 2024, but does not explicitly state the nature or magnitude of changes in the body of the 8-K.
Guidance, Outlook, and Risks
The filing notes that a corporate update was provided alongside the financial results. However, the text does not include specific guidance, outlook figures, management commentary, risks, contingencies, or unusual items. The information in Item 2.02 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2024 revenue, net loss, and cash burn figures.
- Verify the company's cash runway and liquidity position as of June 30, 2024.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the corporate update.
- Confirm if there were any changes to the company's forward-looking guidance during the announcement.